Page 70 - Genetics_From_Genes_to_Genomes_6th_FULL_Part2
P. 70

7.2 Molecular Mechanisms That Alter DNA Sequence   229




                         FAST FORWARD                          Sprinters: © Robert Michael/Corbis RF


                         Trinucleotide Repeat Diseases: Huntington Disease and Fragile X Syndrome
                         The approximately 20 known neurogenerative diseases caused   Figure A  Huntington disease: a polyQ repeat disease.
                         by genes with unstable trinucleotide (triplet) repeats fall into two   The HD gene has a run of CAG repeats that specify glutamines
                         categories: polyQ diseases and non-polyQ diseases (where Q is   (Qs) in the open reading frame (ORF). HD disease alleles direct the
                         the symbol for the amino acid glutamine). In polyQ disease genes,   synthesis of a mutant, toxic HD protein with an expanded polyQ
                         the repeated triplet is always CAG, while in non-polyQ disease   region. Pre-mutation alleles with an intermediate number of CAGs
                         genes, the trinucleotide repeat may be either CGG, CTG, GCC, or   produce a normally functioning protein, but the allele is unstable.
                         GAA. The two types of triplet repeat diseases are distinguished   PolyQ disease: Huntington disease
                         by the effect of the repeat sequence on gene function. In polyQ        CAG
                         diseases, a disease allele with too many triplet repeats encodes             36–120 mutant
                         an abnormal protein. Non-polyQ disease alleles encode either no         CAG  29–35 pre-mutation
                         protein or decreased protein amounts. The differences in the two        CAG 6–28 normal
                         classes of triplet repeat diseases are illustrated by the best-
                         known example of each: Huntington  disease, a polyQ disease;   HD gene     ORF
                         and fragile X syndrome, a non-polyQ disease.             Beginning of gene  PolyQ region
                             Huntington disease affects about 1 in 10,000 people
                         worldwide. The symptoms usually start at about 40 years of
                         age and include muscle coordination difficulties, cognitive de-
                         cline, and psychiatric problems. You saw in Chapter 2 that
                         Huntington disease is inherited through autosomal dominant   Figure B  Fragile X syndrome: a non-polyQ repeat
                                                     +
                         mutant alleles (HD). While normal HD  alleles have between 6   disease. The FMR-1 gene has a run of CGG repeats in the 5′
                         and  28  CAG  repeats,  HD  disease alleles  have an expanded   untranslated region (5′ UTR) outside the ORF. FMR-1 disease
                         repeat region that has 36 or more CAG repeats. The run of   alleles have an expanded repeat number, and this prevents
                         CAGs in the HD gene are in the open reading frame, or ORF,   synthesis of the gene’s protein product. Pre-mutation alleles with
                         that contains the actual instructions to build a protein from its   an intermediate number of CGGs make normal amounts of protein,
                         constituent amino acids.                          but these alleles are unstable.
                             Each CAG specifies that the amino acid glutamine (Q)   Non-polyQ disease: fragile X syndrome
                         should be added to the HD protein, so the normal protein has
                         6 to 28 Q amino acids in a row in its so-called polyQ region           CGG   200–4000 mutant
                         (Fig. A). An HD allele with 36 or more repeats encodes a  mutant       CGG  56–200 pre-mutation
                         HD protein with an expanded polyQ region that is toxic to               CGG 6–55 normal
                         nerve cells. (Proteins encoded by pre-mutation alleles function
                         normally but the alleles have an unstable repeat number.)   FMR-1 gene        ORF
                                                                                             5' UTR
                         Scientists do not yet understand the normal function of HD in   Beginning of gene
                         nerve cells or the reason why the mutant HD protein is toxic.
                             PolyQ disease alleles like  HD are called  gain-of-function
                         mutants  because  they  specify  proteins whose  functions  are
                         qualitatively different from those of the corresponding wild-type     expanded repeats in non-polyQ disease genes generally prevent
                         protein. Typical for many gain-of-function mutants, polyQ  disease   protein production, and so non-polyQ disease genes are loss-of-
                         alleles show dominant inheritance because the mutant polyQ   function alleles. Because females heterozygous for the disease
                         proteins are toxic even in the presence of the normal proteins.  allele have at least some disease symptoms most of the time,
                             Non-polyQ diseases are exemplified by fragile X syn-  fragile X syndrome shows X-linked dominant inheritance with in-
                         drome, a leading cause of inherited intellectual disability, affect-  complete penetrance and variable expressivity. Other non-polyQ
                         ing about 1 in 4000 males and 1 in 8000 females. The disease   disease alleles may show either dominant or recessive inheri-
                         is caused by expansion of a CGG repeat region in an X-linked   tance patterns, depending on whether two doses or one dose of
                         gene called FMR-1 (for fragile X mental retardation-1).  the normal gene product is required to avoid disease symptoms.
                             The CGGs of FMR-1 are located in a region of the gene out-  The triplet repeat diseases illustrate two fundamental prin-
                                                                  +
                         side of the ORF called the 5′ UTR (Fig. B). Normal FMR-1  genes   ciples regarding mutations. First, mutations may affect either
                         have between 6 and 55 CGG repeats; expansion of the repeat   the nature of the gene product (polyQ diseases) or the amount
                         number to 200 CGGs or more results in an FMR-1 disease allele   of the gene product (non-polyQ diseases). Second, certain DNA
                         that cannot produce the FMR-1 protein. Without FMR-1 protein,   sequences can mutate at surprisingly high frequencies in spe-
                         nerve cells cannot properly form connections called synapses.  cial circumstances, as seen by pre-mutation alleles for either
                             A feature common to all non-polyQ diseases is that the trip-  Huntington disease or fragile X syndrome. These two principles
                         lets are located in a part of the gene outside of the ORF. The   will be important themes in subsequent chapters.
   65   66   67   68   69   70   71   72   73   74   75